phosphorylcholine has been researched along with belinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arunan, V; Beloueche-Babari, M; Chung, YL; Griffiths, JR; Jackson, LE; Judson, IR; Leach, MO; Payne, GS; te Fong, AC; te Poele, RH; Troy, H; Workman, P | 1 |
1 other study(ies) available for phosphorylcholine and belinostat
Article | Year |
---|---|
Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Choline Kinase; Colonic Neoplasms; Drug Evaluation, Preclinical; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Nude; Phosphorylcholine; Prostatic Neoplasms; Sulfonamides; Xenograft Model Antitumor Assays | 2012 |